Patents by Inventor Thomas Hoger

Thomas Hoger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Subunits of glutamate receptors, their preparation and their use
    Patent number: 5756697
    Abstract: The invention relates to novel subunits for glutamate receptors and to the DNA sequences coding therefor, and to processes for preparing DNA sequences and receptors. The invention furthermore relates to methods for identifying functional ligands for these receptors.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: May 26, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: Thomas Hoger, Andreas Ultsch, Alfred Bach, Sylvia Sterrer, Hans-Georg Lemaire
  • N-substituted azobicycloheptane derivatives, the preparation and use thereof
    Patent number: 5753690
    Abstract: A compound of the formula ##STR1## in which A, R.sup.1 and n have the meanings stated in the description are described. The novel compounds are suitable for controlling diseases.
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: May 19, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: Gerd Steiner, Rainer Munschauer, Thomas Hoger, Liliane Unger, Hans-Jurgen Teschendorf
  • N-substituted azabicycloalkane derivatives, their preparation and use
    Patent number: 5703091
    Abstract: Compounds of the formula I ##STR1## where B, R.sup.1, R.sup.2, n and A have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
    Type: Grant
    Filed: June 6, 1996
    Date of Patent: December 30, 1997
    Assignee: BASF Aktiengesellschaft
    Inventors: Gerd Steiner, Rainer Munschauer, Liliane Unger, Hans-Jurgen Teschendorf, Thomas Hoger
  • N-substituted azabicycloheptane derivatives, their preparation and use
    Patent number: 5616705
    Abstract: Compounds of the formula I ##STR1## where the substituents have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: April 1, 1997
    Assignee: BASF Aktiengesellschaft
    Inventors: Gerd Steiner, Rainer Munschauer, Liliane Unger, Hans-Jurgen Teschendorf, Thomas Hoger